OTCMKTS:NVZMY - NOVOZYMES A/S/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$45.63 +0.83 (+1.85 %)
(As of 01/18/2019 06:49 AM ET)
Previous Close$44.8050
Today's Range$45.1580 - $45.89
52-Week Range$43.24 - $56.11
Volume35,579 shs
Average Volume43,385 shs
Market Capitalization$13.31 billion
P/E Ratio28.70
Dividend Yield1.10%
Beta0.95
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. It operates in three divisions: Household Care & Technical, Agriculture & Bioenergy, and Food & Beverages. The company offers enzymes for use in household care products, such as laundry detergents, hand and automatic dishwashing soaps, and professional cleaning products. It also provides enzymes for baking applications, including freshness, product appearance, dough improvement, etc.; and brewing applications comprising fermentation control, separation and filtration, etc., as well as for use in lactose-free dairy, trans fats removal, etc. in the food and beverages industry. In addition, the company offers enzymes and microorganisms for use in the production of cellulosic ethanol, starch-based ethanol, enzymatic biodiesel, and sugarcane ethanol in the bioenergy industry; and feed enzymes for use in animal feed, probiotics for animal health applications, microbials for aquaculture applications, and other enzymes and microorganisms for plant health and crop yield applications in the agriculture and feed industry. Further, it provides enzymes and microorganisms for use in textile processing, pulp and paper production, leather preparation, pharmaceuticals, and wastewater treatment solutions. The company has a strategic collaboration with Boehringer Ingelheim Animal Health for research and development, production, marketing, and sale of a portfolio of probiotic products. It also has a collaboration agreement with Elanco Animal Health Incorporated. Novozymes A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Receive NVZMY News and Ratings via Email

Sign-up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:NVZMY
CUSIPN/A
Phone45-4446-0000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.21 billion
Cash Flow$1.9196 per share
Book Value$6.81 per share

Profitability

Net Income$473.62 million

Miscellaneous

Employees6,245
Market Cap$13.31 billion
OptionableNot Optionable

NOVOZYMES A/S/S (OTCMKTS:NVZMY) Frequently Asked Questions

What is NOVOZYMES A/S/S's stock symbol?

NOVOZYMES A/S/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How were NOVOZYMES A/S/S's earnings last quarter?

NOVOZYMES A/S/S (OTCMKTS:NVZMY) announced its quarterly earnings data on Wednesday, October, 24th. The biotechnology company reported $0.43 earnings per share for the quarter. The biotechnology company had revenue of $570.42 million for the quarter. NOVOZYMES A/S/S had a return on equity of 29.84% and a net margin of 22.20%. View NOVOZYMES A/S/S's Earnings History.

When is NOVOZYMES A/S/S's next earnings date?

NOVOZYMES A/S/S is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for NOVOZYMES A/S/S.

What is the consensus analysts' recommendation for NOVOZYMES A/S/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NOVOZYMES A/S/S in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for NOVOZYMES A/S/S.

Has NOVOZYMES A/S/S been receiving favorable news coverage?

Media headlines about NVZMY stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. NOVOZYMES A/S/S earned a daily sentiment score of 0.7 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

Who are some of NOVOZYMES A/S/S's key competitors?

Who are NOVOZYMES A/S/S's key executives?

NOVOZYMES A/S/S's management team includes the folowing people:
  • Mr. Peder Holk Nielsen, Pres & CEO (Age 62)
  • Mr. Thomas Videbaek, Exectuive VP & COO of Research, Innovation & Supply (Age 58)
  • Mr. Andrew Fordyce, Exec. VP of Food & Beverages (Age 55)
  • Mr. Per Falholt, Consultant (Age 60)
  • Dr. Prisca Havranek-Kosicek, CFO & Exec. VP of Corp. Functions (Age 43)

How do I buy shares of NOVOZYMES A/S/S?

Shares of NVZMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NOVOZYMES A/S/S's stock price today?

One share of NVZMY stock can currently be purchased for approximately $45.63.

How big of a company is NOVOZYMES A/S/S?

NOVOZYMES A/S/S has a market capitalization of $13.31 billion and generates $2.21 billion in revenue each year. The biotechnology company earns $473.62 million in net income (profit) each year or $1.59 on an earnings per share basis. NOVOZYMES A/S/S employs 6,245 workers across the globe.

What is NOVOZYMES A/S/S's official website?

The official website for NOVOZYMES A/S/S is http://www.novozymes.com.

How can I contact NOVOZYMES A/S/S?

NOVOZYMES A/S/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The biotechnology company can be reached via phone at 45-4446-0000 or via email at [email protected]


MarketBeat Community Rating for NOVOZYMES A/S/S (OTCMKTS NVZMY)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  209
MarketBeat's community ratings are surveys of what our community members think about NOVOZYMES A/S/S and other stocks. Vote "Outperform" if you believe NVZMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVZMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Featured Article: Float

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel